A Bacillus-based direct-fed microbial impacted growth performance, immune cell presence, and in vivo Salmonella Enteritidis dissemination in growing broiler chickens Authors: M Carroll, K Bolek, VA Uyanga, Sahil Kalia, EA Bobeck Published: 2026 ABSTRACT AbstractBacillus-based direct-fed microbials (DFMs) have previously improved broiler performance and pre-harvest food safety by reducing foodborne pathogens. Therefore, an experiment was conducted to determine the effects of a Bacillus-based DFM on performance and physiological recovery metrics post- Salmonella Enteritidis challenge in growing broiler chicks. 560 male Ross 308 broilers were wingbanded at hatch and distributed among 40 cages (14 chicks/cage). Chicks were allocated into one of two dietary treatment groups, control (CON) or MicroLife® Prime (MLP), ± 1 × 108 CFU Salmonella Enteritidis (SAL) inoculated at 7 d of age, for a total of 4 treatments: 1) CON (corn-soy) diet + sham gavage; 2) CON+SAL gavage; 3) MLP (500,000 CFU/g of feed) + sham gavage; or 4) MLP (500,000 CFU/g of feed) + SAL gavage. Growth performance was measured weekly and at sampling timepoints through study completion on day 21. At 4, 7, and 14 days post SAL inoculation (dpi), liver, spleen, and swab samples were collected for PCR and microbiology. Growth performance data were analyzed using SAS PROC ANOVA. Salmonella prevalence data were analyzed using SAS PROC FREQ chi-squared tests. At day 7 prior to challenge, MLP-fed birds tended to have a 7.75% heavier body weight (BW) than CON (p = 0.057), with a 10.37% improvement in BW gain. At 4dpi, MLP supplementation increased BW by 28.9 g, increased FI by 15.4 g, and improved FCR from 1.441 to 1.186 (main effect: p < 0.05). No Salmonella was present at baseline prior to inoculation. Cloacal swab SAL prevalence at 4dpi was significantly higher by 70% in CON+SAL vs. unchallenged treatments with 0% prevalence (p = 0.004), with MLP+SAL being statistically intermediate at 40% prevalence. Baseline splenic interleukin (IL)-17 was significantly upregulated two-fold due to MLP (p = 0.02). MLP downregulated IL-4 expression by 57% in baseline liver samples while increasing IFN-γ by 60% compared to control (P < 0.05), with a trend for MLP to reduce IL-17 expression by 41%. Feeding MLP improved BW and regulatory/ pro-inflammatory cytokine expression prior to challenge, with positive effects carrying over during SAL challenge.Keywords: Broiler, Direct-fed microbial, Immune response, Salmonella Introduction Varying probiotic strains and combinations have been developed for use in poultry production, with many of them being based on common strains of the genus Bacillus spp (Krysiak et al., 2021). The benefits of probiotics in general range from support of a healthy intestinal microbiome, immune system stimulation, competitive exclusion, or improved nutrient absorption, to direct impacts on disease outcomes, performance, and product quality (Naeem and Bourassa, 2025). Importantly, each probiotic strain has a specific mechanism of action and therefore, probiotic products are not “one size fits all”, rather, a specific probiotic must be selected based on needs within the flock (Kabir, 2009; Krysiak, et al., 2021). Members of the genus Bacillus are Gram-positive, catalase-producing, spore-forming, rod-shaped bacteria that are found across environments, and are considered intestinal commensals (Cutting, 2011). A key advantage over other probiotic species is their spore-forming ability, which allows them to survive conditions such as pelleting and the acidic stomach environment, and resume viability under favorable conditions (Vieco-Saiz, et al., 2024). While Bacillus spp are aerobes, they can also survive in anoxic conditions through the use of nitrate or nitrite as a terminal electron acceptor, and therefore can exert function in different locations within the gastrointestinal tract (Cartman, et al., 2008). Probiotics may act differently when in an in vivo environment for many different reasons. Factors that influence efficacy include probiotic strain and supplementation level, timing and duration of administration, other diet and environmental conditions, interaction with other feed components, and factors related to the host (Naeem and Bourassa, 2025). When assessing a probiotic for utility, it is crucial that the probiotic is evaluated within the context of known modes of action. Therefore, a significant amount of work has been completed over the last 20+ years to understand the effects of probiotics in combination, supplementation level, and environment to provide feedback to continually improve existing probiotics and identify the environments in which they provide the most benefit. One of the overarching characteristics of the Bacillus genus is their rapid growth within the gastrointestinal tract, a feature which is crucial for optimizing function, because growth rate influences capacity for metabolic activity and therefore affects the mechanisms of action (Cartman, et al., 2008; Latorre, et al., 2014). For example, a Bacillus subtilis 29784- based probiotic was found to produce bioactive metabolites which may have functionally improved the immune response, intestinal barrier, and also modulated production of beneficial fermentation products, including butyrate (Vieco-Saiz, et al., 2024). Mechanisms of action are not mutually exclusive, as a particular probiotic can function with one or a combination of several mechanisms, and these mechanisms can further change based on probiotic composition (Ramlucken, et al., 2020). Specific Bacillus strains have been studied for their benefits against intestinal pathogens including Clostridium perfringens and Salmonella spp (Ramlucken, et al., 2020). Other reports have found that specific strains of Bacillus subtilis (DSM117299) significantly reduce Salmonella enterica serovar Enteritidis colonization in broilers (Knap et al., 2011). A knowledge gap exists in the mechanism of action of a particular combination of Bacillus spp, namely Bacillus subtillis, Bacillus licheniformis, Bacillus coagulans and Bacillus amyloliquefaciens against common pathogens affecting poultry during production. Previous work has reported efficacy of this combination in alleviating negative performance effects and inflammatory markers associated with coccidiosis in poultry (Osho, et al., 2023). With efficacy against Salmonella shown in previous work, an experiment was conducted to understand the impact of feeding a combination of Bacillus subtillis, Bacillus licheniformis, Bacillus coagulans and Bacillus amyloliquefaciens during a Salmonella Enteritidis challenge in growing broiler chicks. Material and methods The Iowa State University Institutional Animal Care and Use Committee (IACUC #19-156) approved all animal protocols in this experiment. 560 male Ross 308 broilers were transported from Welp Hatchery (Bancroft, IA) to Laboratory Animal Resources (LAR) unit at Iowa State University (Ames, IA). Chicks were wingbanded upon arrival and placed into raised-wire floor cages within a brooder unit (14 chicks/cage, 10 cages/treatment; Petersime Model 2SD20RE; Gettysburg, OH). Birds were inspected 3 times each day and high/low temperature and humidity were recorded daily. Chicks were assigned to 1 of 2 dietary treatments consisting of: 1) control (corn-soybean basal diet + 0.0125% sand as filler; Table 1) or 2) control + 0.0125% MicroLife® Prime (MLP, 530,000 CFU/g of complete feed; Table 1), and 1 of 2 challenge conditions; 1) oral PBS (sham gavage) or 2) oral gavage with 0.5 ml PBS containing 1 × 108 CFU of Salmonella enterica serovar Enteritidis (SAL; source: Southern Poultry Research Group) at day 7. Each diet had a control and SAL challenge for a total of 4 treatments in a 2 × 2 factorial arrangement. Table 1Composition of the starter diets fed to Ross 308 broilers from day 0 to day 21.Table 1 dummy alt textIngredients, %Control+ MLPCorn54.5054.50Soybean meal 4838.8538.85Soy oil1.581.58Salt0.410.41DL Methionine0.370.37Lysine HCl0.210.21Threonine0.070.07Limestone0.890.89Dicalcium Phos2.122.12Choline chloride 600.350.35Vitamin premix10.640.64Sand0.0125-MicroLife® Prime2-0.0125Fat4.164.16Crude protein23.7223.72ME, kcal/kg29752975Digestible Lys1.471.47Digestible Met0.730.73Digestible Arg1.601.60Digestible Thr0.980.98Dry matter89.8890.70Crude fat4.844.92Crude protein21.2421.48Gross energy, kcal/kg382338151Vitamin and mineral premix provided per kg of diet: selenium 250 mg; Vitamin A (retinyl acetate) 8,250 IU; cholecalciferol (vitamin D3) 2,750 IU; a-tocopherol acetate (vitamin E) 17.9 IU; menadione 1.1 mg; vitamin B12 12 mg; biotin 41 mg; choline 447 mg; folic acid 1.4 mg; niacin 41.3 mg; pantothenic acid 11 mg; pyridoxine 1.1 mg; riboflavin 5.5 mg; thiamine 1.4 mg; iron 282 mg; magnesium 125 mg; manganese 275 mg; zinc 275 mg; copper 27.5 mg; iodine 844 mg.2The 0.0125% inclusion of MicroLife® Prime is equivalent to 530,000 CFU/g of finished feed. Composition of the starter diets fed to Ross 308 broilers from day 0 to day 21. Vitamin and mineral premix provided per kg of diet: selenium 250 mg; Vitamin A (retinyl acetate) 8,250 IU; cholecalciferol (vitamin D3) 2,750 IU; a-tocopherol acetate (vitamin E) 17.9 IU; menadione 1.1 mg; vitamin B12 12 mg; biotin 41 mg; choline 447 mg; folic acid 1.4 mg; niacin 41.3 mg; pantothenic acid 11 mg; pyridoxine 1.1 mg; riboflavin 5.5 mg; thiamine 1.4 mg; iron 282 mg; magnesium 125 mg; manganese 275 mg; zinc 275 mg; copper 27.5 mg; iodine 844 mg. The 0.0125% inclusion of MicroLife® Prime is equivalent to 530,000 CFU/g of finished feed. Feed and water were provided ad libitum, and the basal diet was formulated according to Ross 308 nutrition specifications (Aviagen, 2022). The experiment was conducted in wire cages to prevent continued inoculation of birds from fecal-oral transmission. The daily removal of feces from trays under the cages ensured the initial inoculation was synchronized across cages and birds were not subsequently re-inoculated. Challenged birds were raised in a separate brooder stack and room than the controls to help minimize cross-contamination between cages of challenged and unchallenged birds. The authors acknowledge there are limitations to the application of performance data for broilers raised in wire cages compared to floor pens. Birds were weighed as a pen at 0, 7, 11, 14, and 21 days. Mean body weight (BW) and body weight gain (BWG) were calculated and averaged by bird. Feed intake/disappearance (FI) was recorded throughout. Feed conversion ratio (FCR) was calculated by pen, averaged per bird, and corrected for mortality. At baseline prior to inoculation and 4, 7 and 14 days post-inoculation (dpi), one chick/cage (10 chicks/treatment) was CO2-anesthetized for blood collection by cardiac puncture before euthanasia by cervical dislocation. Anesthetization prior to cardiac puncture is required by IACUC. Other organizations including the National Centre for the Replacement (2026) states cardiac puncture must be performed under terminal anesthesia. In the current study, birds were placed in a CO2 chamber until unresponsive, as determined by cessation of movement, breathing, and loss of blink reflex. Blood was collected via cardiac puncture, and birds were secondarily euthanized using cervical dislocation. Gerritzen et al. (2000) describe the anesthetization of broilers from CO2 as the loss of posture, followed by convulsions. Cloacal swabs were then collected from each bird, and liver/spleen and ceca were removed to verify systemic infection post-challenge. Liver and spleen samples were isolated for gene expression analysis. Salmonella culture for oral gavage On the day before inoculation, 50 mL of tryptic soy broth (TSB) was inoculated with S. Enteritidis stock, incubated aerobically at 37°C, and passaged every 8 h to achieve log phase growth. After 24 h, the most recently passaged culture was washed 3 times in sterile PBS by centrifugation (1,800 × g, 15 min, 4°C). The cell pellet was resuspended in 1 mL of sterile PBS and the optical density of the stock solution at 600 nm (OD600) was measured using a spectrophotometer to estimate stock colony forming units (CFU) density. Salmonella Enteritidis stock was diluted to 1 × 108 CFU/mL and 0.5 mL was orally administered to each chick on d7 of age. The final inoculum was serially diluted and plated on tryptic soy agar (TSA) and incubated aerobically at 37°C overnight to confirm S. Enteritidis CFU. Microbiological analysis of sampled tissues Gastrointestinal tract prevalence of Salmonella Enteritidis were determined by Salmonella colony growth on xylose lysine tergitol 4 (XLT4) agar plates as previously described (Jones-Ibarra, et al., 2019; Larsen, et al., 2022). Briefly, cloacal fecal matter was swabbed using a sterile technique from individual birds. Swabs were transported back to the laboratory, streaked onto XLT4 agar plates using aseptic techniques, and incubated at 42°C for at least 24 h to allow for Salmonella recovery. Cecal swab samples were diluted in 1 mL PBS (pH 7.0) and 0.25 ml of diluted cecal samples were aseptically inoculated into 10 ml Rappaport Vassiliadis (RV) broth and incubated for 24 h at 42°C for Salmonella selective enrichment. Individual liver and spleen samples were combined by gentle maceration using two new, clean frosted microscope slides per sample. Then 5 g of the mixture was placed into a 15 mL conical vials containing 10 ml PBS, homogenized gently with a vortex, and thereafter 1 mL was transferred to 10 mL RV broth and subjected to selective enrichment. Following selective enrichment, serial dilutions of all tissue samples ranging from 10 to 2 to 10–7 dilutions were made and spread plated on XLT4 agar plates and incubated for 24 h at 42°C before inspecting for Salmonella-typical colonies. Samples producing Salmonella-typical colonies (black on red background) were recorded at 24 h. mRNA isolation and qPCR analysis Liver and spleen samples were excised from 6 chicks/treatment/timepoint (baseline d7, d11, d14, d21) placed in RNAlater Stabilization Solution (Invitrogen, MA, U. S.) overnight, then removed from the solution and placed in −80°C for future analysis. RNA was isolated from 24 liver and spleen samples across each sampling timepoint using the RNeasy Mini Kit (Qiagen, MD, U.S.). Isolated RNA was DNAse treated and diluted to 50 ng/ul for QuantiNova One-Step SYBR Green RT-PCR kit (Qiagen, MD, U.S.), and tested against 6 immune-related genes and a chicken housekeeping gene as previously described (Meyer and Bobeck, 2023). Primers included: GAPDH, IL-4, IL-10, Il-17A, IL-1β, IL-23, and IFN-γ (Fries-Craft, et al., 2021). Forward and reverse sequences of all primers are outlined in Table 2. Means are reported as adjusted Ct values, calculated as follows: 40-[(MeanCttest gene + [(Median 28 s)-(MeanCt28S)]. Table 2Forward and reverse primer sequences used in PCR analysis.Table 2 dummy alt textGeneForward sequenceReverse sequenceGAPDHGGTGGTGCTAAGCGTGTTATACCTCTGTCATCTCTCCACAIFN-γAGCTGACGGTGGACCTATTATTGGCTTTGCGCTGGATTCIL-4AACATGCGTCAGCTCCTGAATTCTGCTAGGAACTTCTCCATTGAAIL-10CGGGAGCTGAGGGTGAAGTGAAGAAGCGGTGACAGCIL-17ACTCCGATCCCTTATTCTCCTCAAGCGGTTGTGGTCCTCATIL-1βGCTCTACATGTCGTGTGTGATGAGTGTCGATGTCCCGCATGAIL-23AGGCGGTGCTGGAGGAGCATGACGGCGGTGAAGGAbbreviations: GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; IFN-γ: Interferon gamma.IL-4: Interleukin 4; IL-10: Interleukin 10; IL-17A: Interleukin 17A; IL-1β: Interleukin 1 beta; IL-23: Interleukin 23. Forward and reverse primer sequences used in PCR analysis. Abbreviations: GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; IFN-γ: Interferon gamma. IL-4: Interleukin 4; IL-10: Interleukin 10; IL-17A: Interleukin 17A; IL-1β: Interleukin 1 beta; IL-23: Interleukin 23. Statistical analysis Data were analyzed using SAS version 9.4 (SAS Institute Inc., Cary, NC). PROC UNIVARIATE was used to assess the distribution of all data prior to analysis. Growth performance and gene expression data were normally distributed and were analyzed by PROC ANOVA and mean comparisons between diets were evaluated by Tukey’s HSD. Salmonella prevalence data were analyzed using the Chi-Square method in PROC FREQ; subsequent separation of treatment distributions was performed utilizing Fisher’s exact test for small sample size and Bonferroni’s correction for multiple comparisons. Prevalence data are presented as positive Salmonella percentage, and all other data are presented as mean ± SEM. The significance level for statistical differences was P < 0.05, and a tendency towards significant differences at 0.05 < P < 0.10. Results Performance Performance was measured and analyzed both weekly and on sampling days post-inoculation. At day 7, MLP-fed birds tended to have a 7.75% heavier BW than control (Table 3; p = 0.057). Body weight gain showed a tendency of 10.37% improvement by MLP supplementation (p = 0.059; Table 3), while FCR was numerically but not statistically improved by 12 points (p = 0.120). Week 1 FI was not changed by diet. At day 14 (7dpi), the MLP diet had a main effect of increasing FI by an average of 27 g across both challenge conditions compared to the unchallenged control (p = 0.019; Table 3). At d14, birds supplemented with MLP were 29.8 g heavier than CON, with CON+SAL and MLP+SAL statistically intermediate (p = 0.029; Table 3). CON+SAL groups had significantly reduced FCR by 10 points on average compared to all other treatments at d14 (p = 0.022: Table 3). At d21 (14dpi), a SAL challenge main effect increased FCR (p = 0.016; Table 3) while also reducing BW, FI, and BWG (p < 0.0001; Table 3). Table 3Weekly performance outcomes of experimental birds.Table 3 dummy alt textP-ValueAgeVariableControlMLPPooled SEMDietd7BW (g)141.8153.74.300.057FI (g)104.7108.82.960.326BWG (g)102.9114.84.320.059FCR0.9780.9520.01160.120AgeVariableControlMLPCON+SALMLP+SALPooled SEMDietChallengeDiet *Challenged14BW (g)411.7443.8416.3417.912.400.1820.3950.227FI (g)300.4b346.5a312.1b320.0a11.030.0190.5050.092BWG (g)257.6b287.4a283.4ab267.0ab9.980.5130.7900.029FCR1.226a1.209a1.110b1.201a0.02240.1100.0100.022AgeVariableControlMLPCON+SALMLP+SALPooled SEMDietChallengeDiet *Challenged21BW (g)832.8a866.9a762.2b777.8b17.750.169<0.00010.605FI (g)582.5a580.3a516.5b521.8b9.830.877<0.00010.705BWG (g)421.1a423.1a345.9b359.9b14.330.579<0.00010.679FCR1.389b1.382b1.508a1.468ab0.04030.5600.0160.692Calculated values represent performance from that week, for example, day 0-7, d7-14, and d14-21. Data in the same row with different alphabetical superscripts differ significantly at P < 0.05. Abbreviations: BW, body weight; BWG, body weight gain; FI, feed intake; FCR, feed conversion rate. Weekly performance outcomes of experimental birds. Calculated values represent performance from that week, for example, day 0-7, d7-14, and d14-21. Data in the same row with different alphabetical superscripts differ significantly at P < 0.05. Abbreviations: BW, body weight; BWG, body weight gain; FI, feed intake; FCR, feed conversion rate. At an intermediate sampling timepoint corresponding to d11 (4dpi) between d7 and 14, birds and feed were weighed to determine impact on performance measures. Diet significantly impacted BW, FI, and FCR at d11 (P < 0.05; Table 4). MLP had a main effect of increased BW by 28.9 g, increased FI by 15.4 g, and an improved FCR by 20.5 points (P < 0.05; Table 4). From d11-14, FI was significantly reduced by 13.1 g due to challenge (p = 0.001; Table 4). From d11-14, BWG was significantly reduced by 17 g due to MLP diet (p = 0.01; Table 4). Table 4Performance outcomes, presented at 3 and 7 dpi sample timepoints post-challenge.Table 4 dummy alt textP-ValueAgeVariableControlMLPCON+SALMLP+SALPooled SEMDietChallengeDiet *Challenged11BW(g)266.7b304.4a263.5b283.5a13.200.0360.3690.505(d7-11)FI(g)144.6b172.3a154.2b159.7a4.190.0090.8010.071(d7-11)BWG (g)102.4b147.9a130.7ab132.6a9.680.0210.5150.033(d7-11)FCR1.652a1.165b1.229b1.207b0.0940.0120.0530.021AgeVariableControlMLPCON+SALMLP+SALPooled SEMDietChallengeDiet *Challenged14BW (g)411.7443.8416.3417.912.400.1820.3950.227d11-14FI (g)170.2a174.2a157.8b160.4b3.420.3450.0010.831d11-14BWG (g)155.2a139.5b152.7a134.4b6.170.0100.5540.840d11-14FCR1.103b1.263a1.047b1.237a0.0367<0.00010.2820.691Data in the same row with different alphabetical superscripts differ significantly at P < 0.05.Abbreviations: BW, body weight; BWG, body weight gain; FI, feed intake; FCR, feed conversion rate. Performance outcomes, presented at 3 and 7 dpi sample timepoints post-challenge. Data in the same row with different alphabetical superscripts differ significantly at P < 0.05. Abbreviations: BW, body weight; BWG, body weight gain; FI, feed intake; FCR, feed conversion rate. Microbiology Salmonella was not found to be present in any tissue sampled prior to Salmonella inoculation on day 7 (Table 5). In cloacal swabs taken at 4 dpi, there was significantly more Salmonella present in the Salmonella-challenged treatment compared to the control and MLP treatments (70% vs 0%, respectively; p = 0.0004; Table 5), while MLP+SAL was intermediate but not different from CON+SAL or groups without SAL treatment. The distribution of Salmonella prevalence was significantly different at 7 dpi in the cloacal swabs (p = 0.0376), however, subsequent pairwise comparisons could not statistically separate the treatment distributions. The MLP+SAL treatment had a prevalence of 40% and the CON+SAL treatment prevalence was 20%, while the control and MLP treatments showed no presence of Salmonella in cloacal swabs 7 dpi (Table 5). No statistically different outcomes were found at later timepoints within this swabbing location. Table 5Salmonella prevalence from cloacal swabs, ceca, and liver/spleen samples at baseline, 4, 7, and 14 dpi.Table 5 dummy alt textControlMLPCON + SALMLP + SALP-valueCloacal swabs Baseline0%0%0%0%1.000 4 dpi0%a0%a70%b40%ab0.0004 7 dpi0%0%20%40%0.038 14 dpi0%0%10%10%1.000Ceca Baseline0%0%0%0%1.000 4 dpi20%50%50%50%0.425 7 dpi10%30%50%50%0.186 14 dpi0%a0%a60%b30%ab0.002Liver/Spleen Baseline0%0%0%0%1.000 4 dpi0%a30%ab60%b40%ab0.030 7 dpi0%0%10%30%0.167 14 dpi0%0%20%0%0.231Values are presented as a percentage of positive XLT plates of Salmonella-typical colonies (n = 10/ treatment). Subsequent Chi-squared pairwise comparisons were used to separate treatments within significant tests, using Bonferroni’s multiple comparison correction for 6 pairwise comparisons at P < 0.0083. Salmonella prevalence from cloacal swabs, ceca, and liver/spleen samples at baseline, 4, 7, and 14 dpi. Values are presented as a percentage of positive XLT plates of Salmonella-typical colonies (n = 10/ treatment). Subsequent Chi-squared pairwise comparisons were used to separate treatments within significant tests, using Bonferroni’s multiple comparison correction for 6 pairwise comparisons at P < 0.0083. No differences in cecal swabs were found until 14 dpi, where CON+SAL resulted in a 60% Salmonella prevalence rate, which was significantly greater than 0% in the control and MLP treatments without Salmonella (Table 5; p = 0.0019). The MLP+SAL treatment resulted in a 30% prevalence rate, which was intermediate between non-Salmonella treated groups and CON+SAL (Table 5). Within the combined liver and spleen samples, 4 dpi was the only statistically significant timepoint (Table 5), with significantly greater prevalence of Salmonella in the CON+SAL treatment compared to the CON (60% vs 0%, respectively; p = 0.0304). The MLP and MLP+SAL treatments were intermediate, with 30% and 40% Salmonella prevalence, respectively. Spleen PCR At baseline, IL-17 was significantly upregulated two-fold due to MLP in spleen tissue (p = 0.02; Fig. 1A). At 4 dpi, IL-1β and IL-4 were upregulated 3 fold and 2.5 fold, respectively in MLP+SAL vs MLP only (Fig. 1B; P < 0.0002). Relative IL-10 and IL-17 expression in MLP, CON+SAL, and MLP+SAL were 3-4 times higher compared to control (Fig. 1B; p = 0.001). IL-23 was upregulated in CON+SAL vs MLP (Fig. 1B; p < 0.05). At 7 dpi, IL-1β and IL-17 remained upregulated due to MLP+SAL, similar to 4 dpi (Fig. 1C; P < 0.001). A main effect of MLP increased IL-4 expression 2-fold at 7 dpi (Fig. 1C; P < 0.001). By 14 dpi, MLP+SAL maintained an increased IL-4 and IL-17 expression compared to all other treatment groups (Fig. 1D, P < 0.01). A main effect of SAL resulted in increased IL-1β expression 2.5-fold (Fig. 1D: p = 0.0008). Splenic mRNA expression levels of pro- and anti-inflammatory cytokines. Spleen PCR samples were collected from 6 chicks/ treatment/ timepoint prior to and post-challenge. Data are representative of means ± StErr with significance denoted by differing letters (P < 0.05). Liver PCR In baseline liver samples, MLP downregulated IL-4 expression while increasing IFN-γ compared to control (Fig. 2A; P < 0.05), with a trend for MLP to reduce IL-17 (p = 0.08; Fig. 2A). After the introduction of Salmonella, 4dpi samples resulted in significant reductions in IL-1β in birds fed CON+SAL and MLP+SAL, with MLP intermediate (Fig. 2B; P < 0.05). IL-10 was downregulated in all groups compared to control, while IL-17 and IL-23 were significantly downregulated in all MLP groups compared to control (P < 0.05; Fig. 2B). IFN-γ expression was significantly reduced in MLP+SAL compared to control and CON+SAL (P < 0.05; Fig. 2B). IL-4 was significantly upregulated 1.25-fold in CON+SAL compared to all other groups (P < 0.05; Fig. 2B). Hepatic mRNA expression levels of pro- and anti-inflammatory cytokines. Liver PCR samples were collected from 6 chicks/ treatment/ timepoint prior to and post-challenge. Data are representative of means ± StErr with significance denoted by differing letters (P < 0.05). At 7 dpi, IL-1β was significantly upregulated in MLP+SAL vs. MLP and CON+SAL (Fig. 2C; P < 0.05). IL-4 was upregulated due to the main effects of Salmonella (Fig. 2C; P < 0.05). IL-17 and IFN-γ were upregulated in MLP+SAL compared to all other groups (Fig. 2C; P < 0.001). At 14 dpi, MLP+SAL resulted in significantly increased expression in IL-1β, IL-4, IL-10, IL-23, and IFN-γ compared to all other treatments (P < 0.001; Fig. 2D). IL-17 was reduced in MLP compared to CON, with other treatments remaining intermediate (P < 0.05; Fig. 2D). Discussion Probiotics have been employed in commercial poultry diets over the last 15+ years for an array of reasons, including improving the response to pathogenic bacteria (Cutting, 2011; Gareau, et al., 2010; Krysiak, et al., 2021). Because poultry environments challenge growing birds in several ways, it would be crucial to evaluate probiotics using a challenge model. Therefore, a S. Enteriditis (SAL) challenge model was employed to further understand the effects of a Bacillus-based probiotic on growing chick performance, host tissue responses, and microbiological outcomes. Performance Performance results indicate that prior to challenge, MLP inclusion tended to increase d7 chick body weight by 7.7%. Early improvements to BW typically translate to improved finishing weight and also indicate that the digestive tract and muscle tissues are maturing properly (Gaweł, et al., 2022). The improvements in BW gain in the first week also translated to a significantly improved FCR prior to Salmonella inoculation (Table 3). The data therefore support that MLP improved growth performance in the first week of life prior to the chicks experiencing a challenge. The SAL challenge negatively impacted FCR in the first week post-inoculation. In body weights assessed during the SAL challenge, at 4 dpi, chicks fed MLP remained significantly heavier than those challenged but fed a control diet. By d14 (7dpi), there was no difference in body weight due to diet. In terms of experiencing and recovering from a challenge, the BW data indicate that early BW increases due to MLP could have provided a benefit to chicks during the SAL challenge. While probiotics operate under a variety of mechanisms, other recent reports where investigators have fed Bacillus-based probiotics to broiler chicks support that there is likely a growth or performance benefit (Cai, et al., 2024; Madej, et al., 2025). Microbiology The colonization of Salmonella in the distal portion of the gastrointestinal tract of avian species is partly dependent on microbiome diversity (Pedrosos et al., 2021) and type III secretion system (Bäumler et al., 1998) responsible for inflammatory response, creating a favorable climate for proliferation (Thiennimitr et al., 2011). The increased presence of Salmonella in the distal intestinal tract, cloaca and ceca, shortly after inoculation in the current study is expected; in agreement with findings from Murate et al. (2015) where almost all cloacal swabs 7 dpi were positive for Salmonella. The decrease in Salmonella presence in cloacal swabs 7 and 14 dpi may indicate a decrease in shedding, however, not the absence of colonization in other anatomical structures (Gast et al., 2020), as indicated by the presence of Salmonella in cecal contents 4, 7, and 14 dpi in the current study. Microbial populations vary greatly in the first 21 days in chickens as the intestinal flora attempts to stabilize (Lu et al., 2003). The protagonistic and antagonistic relationship between commensal bacterial communities and Salmonella during early growth plays a key role in the ability of Salmonella to colonize the avian ceca (Lu et al., 2003; Pedroso et al., 2021). The broiler chicks utilized in the current study were not tested for Salmonella upon receipt from the hatchery. Despite no positive Salmonella presence at d7 prior to inoculation, communities of Salmonella could have been present in the chick’s ceca cultivating a permissive environment (Azcarate-Peril et al., 2018; Pedroso et al., 2021), resulting in Salmonella positives within unchallenged groups in the current study. Other investigators have used Bacillus-based probiotics specifically for the Salmonella-reducing properties, so this outcome aligns with others’ results of Bacillus-based products reducing SAL load (Knap et al., 2011; Shanmugasundaram, et al., 2020; Soffritti, et al., 2025). Another possibility for Salmonella positive samples from unchallenged birds is cross-contaimination in the laboratory during culturing. Necessary precautions to prevent cross-contaimination were taken, however all samples were incubated in the same incubator. The competitive exclusion principle for probiotics mode of action involves a multitude of microbe-microbe interactions (Lu et al., 2003; Azcarate-Peril et al., 2018; Pedroso et al., 2021), which are not easily understood. Broilers supplemented with MLP in the current study showed a decrease from 50% prevalence of Salmonella 4 dpi to 0-30% prevalence in the ceca in contrast to the Salmonella challenged treatment without MLP supplementation increasing from 50% to 60% in the same timeframe. The translocation of Salmonella from the gastrointestinal tract to internal organs is indicative of a more severe systemic infection (Sania et al., 2022); liver and spleen samples being common indicators as they serve important roles in the immune response of the host (Sania et al., 2022). While the MLP unchallenged group saw an increase in Salmonella prevalence 4 dpi in the liver and spleen compared to the unchallenged control, they also showed a higher prevalence in the ceca during the same time. Higher prevalence of Salmonella at 4 dpi in the liver and spleen decreased by 7 and 14 dpi while the prevalence of Salmonella remained elevated in the ceca. PCR Cytokines that play roles in both pro-and anti-inflammatory processes were assayed in two tissues, the spleen and liver, prior to and post-SAL challenge. IL-4 and IFN-γ are two cytokines that play primary roles in the response to Salmonella in poultry (Chaudhari, et al., 2018). IL-4, along with IL-10, are anti-inflammatory cytokines which inhibit the inflammatory response (Han, et al., 2020). Pathogens also use these host pathways as evasion mechanisms. Among other roles, IFN-γ promotes inflammatory cascades and clearance responses to bacteria (Shaji, et al., 2023). Prior to SAL exposure, MLP generally induced regulatory type responses in liver and spleen tissues through increased IL-17 expression. At both 4 and 7 dpi, the expression of several cytokines were upregulated in birds fed MLP and challenged with SAL, including pro-inflammatory IL-1β, but also IL-4, IL-10, and IL-17, which represents an interesting balanced pro-and anti-inflammatory response in the spleen. A similar profile was found in this group at 7 and 14 dpi in the liver. Although in ileal and cecal tissue, other reports have found upregulation of IL-1β at 5 and 10d post-Salmonella Typhimurium inoculation (Fasina, et al., 2008). In previous reports, IL-23 has been found to play a role in early protective immunity against intracellular pathogens, and may play a role in the promotion of IFN-γ expression (Truong, et al., 2017). At 4 dpi in the liver, both IL-23 and IL-17 were found to be significantly reduced due to MLP. This could potentially indicate that MLP was producing a more regulated inflammatory environment. By 7 dpi, IL-1β, IL-17, and IFN-γ showed increased expression in the liver in MLP+SAL, while a similar pattern was already found by 4 dpi in CON+SAL. This outcome, taken together with the cloaca and liver/spleen swab outcomes, points to a tissue delayed response post-inoculation that may have reduced the impact of SAL on circulation within the bird due to MLP. Taken together with performance data, MLP may have BW benefit when fed prior to a challenge that prepares chicks and immune regulation during challenge. Importantly, the advantage that MLP provides with early increased BW is likely to translate to downstream improvements in BW at the end of the production cycle. If MLP is acting as a positive FI agent, that would additionally support the gastrointestinal physiology during challenges. While DFMs may not be able to rescue losses associated with inoculation challenges, an improved recovery time or aiding feed intake during the challenge may provide a benefit for practical applications. The PCR data and swabs indicate there is likely a benefit of MLP during the SAL challenge implemented in this work. This overall benefit could be in the form of dampening systemic impacts of SAL, altering inflammatory response cascades/ timelines, and promoting a more regulated environment. Feeding MLP showed improved performance pre-challenge and immune modulation during challenge. Conflict of Interest Statement for “A Bacillus-based direct-fed microbial impacted growth performance, immune cell presence, and in-vivo Salmonella Enteritidis dissemination in growing broiler chickens” Author Contribution MC - was responsible for data curation, the formal analysis, and primary author in writing of the manuscript. KB - was responsible for study conception, funding acquisition, and review of the manuscript. VAU - assisted with data curation and review of the manuscript. SK - performed the animal experiment and aided in review of the manuscript. EAB - oversaw administration of the project, acquired the funding, developed the methodology for the experiment, animal experiment, data curation, and critically reviewed and revised the manuscript. All authors have read and approved the final version and agree to be accountable for all aspects of the work. Disclosures The authors declare no conflict of interests.